Join Growin Stock Community!

Milestone scientific inc.MLSS.US Overview

US StockHealthcare
(No presentation for MLSS)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

MLSS AI Insights

MLSS Overall Performance

MLSS AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

MLSS Recent Performance

-2.91%

Milestone scientific inc.

0.05%

Avg of Sector

-0.31%

S&P500

MLSS PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

MLSS Key Information

MLSS Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

MLSS Profile

Milestone Scientific Inc. designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Livingston, New Jersey.

Price of MLSS

MLSS FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

MLSS Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.08
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
2.33
PB Ratio
8.07
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
71.86%
Net Margin
-74.66%
Revenue Growth (YoY)
0.59%
Profit Growth (YoY)
-0.26%
3-Year Revenue Growth
2.13%
3-Year Profit Growth
4.14%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.08
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
2.33
PB Ratio
8.07
Price-to-FCF
-
Gross Margin
71.86%
Net Margin
-74.66%
Revenue Growth (YoY)
0.59%
Profit Growth (YoY)
-0.26%
3-Year Revenue Growth
2.13%
3-Year Profit Growth
4.14%
  • When is MLSS's latest earnings report released?

    The most recent financial report for Milestone scientific inc. (MLSS) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MLSS's short-term business performance and financial health. For the latest updates on MLSS's earnings releases, visit this page regularly.

  • What is the operating profit of MLSS?

    According to the latest financial report, Milestone scientific inc. (MLSS) reported an Operating Profit of -1.13M with an Operating Margin of -48.07% this period, representing a growth of 22.78% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is MLSS's revenue growth?

    In the latest financial report, Milestone scientific inc. (MLSS) announced revenue of 2.36M, with a Year-Over-Year growth rate of -6.11%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does MLSS have?

    As of the end of the reporting period, Milestone scientific inc. (MLSS) had total debt of 1.05M, with a debt ratio of 0.12. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does MLSS have?

    At the end of the period, Milestone scientific inc. (MLSS) held Total Cash and Cash Equivalents of 1.35M, accounting for 0.16 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does MLSS go with three margins increasing?

    In the latest report, Milestone scientific inc. (MLSS) did not achieve the “three margins increasing” benchmark, with a gross margin of 69.5%%, operating margin of -48.07%%, and net margin of -48.9%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MLSS's profit trajectory and future growth potential.

  • Is MLSS's EPS continuing to grow?

    According to the past four quarterly reports, Milestone scientific inc. (MLSS)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.01. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of MLSS?

    Milestone scientific inc. (MLSS)'s Free Cash Flow (FCF) for the period is 75.54K, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 107.76% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of MLSS?

    The latest valuation data shows Milestone scientific inc. (MLSS) has a Price-To-Earnings (PE) ratio of -4.48 and a Price/Earnings-To-Growth (PEG) ratio of 0.18. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.